DK4385509T3 - Migalastat-doseringsskema med forbedret farmakokinetik - Google Patents
Migalastat-doseringsskema med forbedret farmakokinetikInfo
- Publication number
- DK4385509T3 DK4385509T3 DK23176366.5T DK23176366T DK4385509T3 DK 4385509 T3 DK4385509 T3 DK 4385509T3 DK 23176366 T DK23176366 T DK 23176366T DK 4385509 T3 DK4385509 T3 DK 4385509T3
- Authority
- DK
- Denmark
- Prior art keywords
- dosing schedule
- improved pharmacokinetics
- migalastat
- migalastat dosing
- pharmacokinetics
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263432235P | 2022-12-13 | 2022-12-13 | |
| US18/315,928 US20240197706A1 (en) | 2022-12-13 | 2023-05-11 | Methods of improving the pharmacokinetics of migalastat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK4385509T3 true DK4385509T3 (da) | 2025-12-08 |
Family
ID=86646511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK23176366.5T DK4385509T3 (da) | 2022-12-13 | 2023-05-31 | Migalastat-doseringsskema med forbedret farmakokinetik |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20240197706A1 (enExample) |
| EP (2) | EP4667050A2 (enExample) |
| JP (1) | JP7757345B2 (enExample) |
| KR (1) | KR20240094973A (enExample) |
| AU (1) | AU2023396459A1 (enExample) |
| CA (1) | CA3201512A1 (enExample) |
| CL (1) | CL2025001743A1 (enExample) |
| CO (1) | CO2025009079A2 (enExample) |
| DE (1) | DE202023003007U1 (enExample) |
| DK (1) | DK4385509T3 (enExample) |
| FI (1) | FI4385509T3 (enExample) |
| IL (1) | IL321404A (enExample) |
| MX (1) | MX2025006897A (enExample) |
| PT (1) | PT4385509T (enExample) |
| TW (1) | TW202423436A (enExample) |
| WO (1) | WO2024129220A1 (enExample) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6274597B1 (en) | 1998-06-01 | 2001-08-14 | Mount Sinai School Of Medicine Of New York University | Method of enhancing lysosomal α-Galactosidase A |
| JP2010523578A (ja) | 2007-03-30 | 2010-07-15 | アミカス セラピューティックス インコーポレイテッド | 薬理シャペロンを用いるファブリー病の治療方法 |
| US9999618B2 (en) * | 2007-04-26 | 2018-06-19 | Amicus Therapeutics, Inc. | Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones |
| SI2252313T1 (sl) | 2008-02-12 | 2015-08-31 | Amicus Therapeutics, Inc. | Postopek napovedovanja odgovora na zdravljenje bolezni s farmakološkim spremljevalcem |
| EA031874B1 (ru) * | 2011-03-11 | 2019-03-29 | Амикус Терапьютикс, Инк. | Способ лечения болезни фабри |
| US20250144240A1 (en) * | 2021-11-03 | 2025-05-08 | Sangamo Therapeutics, Inc. | Methods for use of viral vector constructs for the treatment of fabry disease |
-
2023
- 2023-05-11 US US18/315,928 patent/US20240197706A1/en active Pending
- 2023-05-31 DE DE202023003007.2U patent/DE202023003007U1/de active Active
- 2023-05-31 IL IL321404A patent/IL321404A/en unknown
- 2023-05-31 AU AU2023396459A patent/AU2023396459A1/en active Pending
- 2023-05-31 JP JP2023090210A patent/JP7757345B2/ja active Active
- 2023-05-31 DK DK23176366.5T patent/DK4385509T3/da active
- 2023-05-31 EP EP25199386.1A patent/EP4667050A2/en active Pending
- 2023-05-31 WO PCT/US2023/067656 patent/WO2024129220A1/en not_active Ceased
- 2023-05-31 KR KR1020230070371A patent/KR20240094973A/ko not_active Ceased
- 2023-05-31 FI FIEP23176366.5T patent/FI4385509T3/fi active
- 2023-05-31 CA CA3201512A patent/CA3201512A1/en active Pending
- 2023-05-31 EP EP23176366.5A patent/EP4385509B1/en active Active
- 2023-05-31 PT PT231763665T patent/PT4385509T/pt unknown
- 2023-05-31 TW TW112120343A patent/TW202423436A/zh unknown
-
2025
- 2025-06-12 MX MX2025006897A patent/MX2025006897A/es unknown
- 2025-06-12 CL CL2025001743A patent/CL2025001743A1/es unknown
- 2025-07-03 CO CONC2025/0009079A patent/CO2025009079A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20240094973A (ko) | 2024-06-25 |
| MX2025006897A (es) | 2025-07-01 |
| WO2024129220A1 (en) | 2024-06-20 |
| PT4385509T (pt) | 2025-11-25 |
| IL321404A (en) | 2025-08-01 |
| CO2025009079A2 (es) | 2025-09-29 |
| TW202423436A (zh) | 2024-06-16 |
| CA3201512A1 (en) | 2024-06-13 |
| JP7757345B2 (ja) | 2025-10-21 |
| JP2024084670A (ja) | 2024-06-25 |
| US20240197706A1 (en) | 2024-06-20 |
| DE202023003007U1 (de) | 2025-07-21 |
| EP4385509B1 (en) | 2025-09-03 |
| AU2023396459A1 (en) | 2025-06-26 |
| EP4385509A1 (en) | 2024-06-19 |
| FI4385509T3 (fi) | 2025-12-05 |
| CL2025001743A1 (es) | 2025-10-03 |
| EP4667050A2 (en) | 2025-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3735786A4 (en) | ESIM PROFILE STATUS CHANGE | |
| EP4005253A4 (en) | PRIORITY LANE CHANGE WITH V2X ASSISTANCE | |
| EP3992323A4 (en) | Plated steel material | |
| EP4017504A4 (en) | FULLY STABILIZED OLIGONUCLEOTIDES RICH IN O-METHYL | |
| EP3996272A4 (en) | Conveying device | |
| EP3957763A4 (en) | PLATED STEEL MATERIAL | |
| DK3827895T3 (da) | Rørreaktor med fast leje | |
| DK3781773T3 (da) | Afstandsholder med forstærkningselementer | |
| DK4025189T3 (da) | Doseringsskemaer i forbindelse med Injicerbare paliperidonformuleringer med forlænget frigivelse | |
| DK3816247T3 (da) | Hærderblanding | |
| DK3938201T3 (da) | Geomaterialebane med biologisk nedbrydelige egenskaber | |
| DK3819007T3 (da) | Doseringsplan for anti-bcma-midler | |
| DK4385509T3 (da) | Migalastat-doseringsskema med forbedret farmakokinetik | |
| EP4288751C0 (de) | Dosiersystem | |
| EP4090711A4 (en) | DEPOSIT WITH SOLID RAW MATERIAL | |
| EP3819047C0 (fr) | Matériau en acier optimisé | |
| DK3962534T3 (da) | Proteiner med kardioprotektiv aktivitet | |
| DK3873432T3 (da) | Tetracyclinkomplekser med vedvarende aktivitet | |
| DK3543423T3 (da) | Bæreprofil med et kipelement | |
| ES1270264Y (es) | Boquilla dosificadora | |
| EP4051061C0 (en) | ADJUSTABLE DOSING MEANS | |
| EP4077236A4 (en) | Cement additive | |
| DK4059068T3 (da) | Diaryloxybenzoheterodiazolforbindelser, der er di-substitueret med thie-nothiopheniske grupper | |
| EP3973114C0 (fr) | Elément de construction | |
| EP3912540A4 (en) | BRUSH AND COMPONENT FOR ROBOTS AND ROBOTS |